Abbott joins transcatheter mitral valve replace race

Abbott Labs is jumping on the transcatheter mitral valve replacement (TMVR) bandwagon with an agreement to buy out the rest of Tendyne Holdings and an option to Cephea Valve Technologies, both announced July 30.